Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma
Cardiac sarcoma treatment is challenging for surgeons because of frequent tumor recurrence and poor prognosis. In addition, optimal management of recurrences is not well established. The multi-targeted tyrosine kinase inhibitor, pazopanib, was recently approved for soft-tissue sarcoma. Herein, we pr...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!